EconBiz - Find Economic Literature
    • Logout
    • Change account settings
  • A-Z
  • Beta
  • About EconBiz
  • News
  • Thesaurus (STW)
  • Academic Skills
  • Help
  •  My account 
    • Logout
    • Change account settings
  • Login
EconBiz - Find Economic Literature
Publications Events
Search options
Advanced Search history
My EconBiz
Favorites Loans Reservations Fines
    You are here:
  • Home
  • Search: subject:"zoledronic acid"
Narrow search

Narrow search

Year of publication
Subject
All
discrete event simulation 2 fractures 2 zoledronic acid 2 Air pollution 1 Cost-effectiveness 1 Cost-effectiveness analysis 1 Frauen 1 Hospital 1 Kosten-Wirksamkeits-Analyse 1 Krankenhaus 1 Luftverschmutzung 1 Simulation 1 Women 1 cost-effectiveness 1
more ... less ...
Online availability
All
Free 2
Type of publication
All
Book / Working Paper 2
Type of publication (narrower categories)
All
Graue Literatur 1 Non-commercial literature 1 Working Paper 1
Language
All
English 2
Author
All
Bleibler, Florian 2 König, Hans-Helmut 2
Published in...
All
HCHE Research Paper 1 HCHE research papers 1
Source
All
ECONIS (ZBW) 1 EconStor 1
Showing 1 - 2 of 2
Cover Image
Cost-effectiveness of intravenous 5 mg zoledronic acid to prevent subsequent clinical fractures in postmenopausal women after hip fracture: A model-based analysis
Bleibler, Florian; König, Hans-Helmut - 2016
individuals with a prior hip fracture. A clinical trial (HORIZON-RFT) showed that a yearly dose of 5mg intravenous zoledronic acid … model suggest that yearly 5 mg intravenous zoledronic acid is a cost-effective intervention in postmenopausal women after a …
Persistent link: https://www.econbiz.de/10011442752
Saved in:
Cover Image
Cost-effectiveness of intravenous 5 mg zoledronic acid to prevent subsequent clinical fractures in postmenopausal women after hip fracture : a model-based analysis
Bleibler, Florian; König, Hans-Helmut - 2016
individuals with a prior hip fracture. A clinical trial (HORIZON-RFT) showed that a yearly dose of 5mg intravenous zoledronic acid … model suggest that yearly 5 mg intravenous zoledronic acid is a cost-effective intervention in postmenopausal women after a …
Persistent link: https://www.econbiz.de/10011436826
Saved in:
A service of the
zbw
  • Sitemap
  • Plain language
  • Accessibility
  • Contact us
  • Imprint
  • Privacy

Loading...